KRAS and lung carcinoma: The present study also revealed that EGFR mutations in advanced lung carcinoma were more frequently associated with intra-thoracic metastases to the lung and pleura, and the absence of lymphadenopathy and extranodal invasion, compared to the KRAS and ALK mutations.